Moderna says RSV vaccine is 84% effective at preventing disease in older adults
CNBC (January 17, 2023) –
KEY POINTS
- The RSV vaccine was 83.7% effective at preventing lower respiratory tract disease, defined as two or more symptoms, in people ages 60 and older, according to Moderna.
- RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC.
- Moderna’s RSV vaccine uses the same messenger RNA technology as its successful Covid-19 shots.
HEALTH AND SCIENCE Moderna says RSV vaccine is 84% effective at preventing disease in older adults